Join
Live feed
·
PRReleasevia Quantisnow
ReShape Lifesciences Inc. logo

ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys

ByQuantisnow·Wall Street's wire, on your screen.
RSLS· ReShape Lifesciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RSLS (ReShape Lifesciences Inc.) and more on Quantisnow.